Introduction

Campomelic dysplasia (CD) is a skeletal dysplasia characterized by abnormal facies, multiple congenital anomalies, a typical pattern of skeletal abnormalities, and frequent male-to-female sex reversal. Newborns with CD often die as a result of respiratory insufficiency and congenital anomalies. A small subset of individuals with clinical features of CD lack characteristic long bone bowing and are classified as having acampomelic campomelic dysplasia.

CD results from mutations in the gene that encodes SOX9 gene. SOX9 is a transcription factor and is involved in testis development and in development of the skeleton. It is a master regulator of endochondral ossification. CD is an autosomal dominant condition, and germline mosaicism has been reported. Affected neonates often die in infancy because of respiratory insufficiency secondary to cervical spine instability or airway instability (laryngotracheomalacia). Despite these immediate risks, there are several reports of infants affected with CD who survived the neonatal period, although the prognosis is guarded.

Disorder

Definition

The term campomelic dysplasia is based on the Greek word campomelic, meaning “bent limb.” CD commonly causes skeletal abnormalities, Pierre Robin sequence, and can cause XY sex reversal in 75% of cases. The diagnosis is suspected by skeletal findings often seen on routine prenatal ultrasound (US) and can be confirmed with prenatal or postnatal molecular genetic testing or radiologic findings.

Prevalence and Epidemiology

CD is rare, and specific prevalence data are unavailable. CD does not have specific ethnicity or sex preponderance.

Infants with CD generally die shortly after birth as a result of respiratory insufficiency secondary to airway compromise or cervical spine instability. Interestingly, newborns with CD die of respiratory compromise, yet their chest size is frequently normal, suggesting underlying lung pathology.

Etiology, Pathophysiology, and Embryology

CD is an autosomal dominant disorder resulting from de novo mutations in the SOX9 gene. Most affected individuals have an identifiable mutation. Heterozygosity for mutations involving missense mutations, nonsense mutations, deletion of the coding region, and occasionally chromosomal rearrangements that disrupt the regulatory regions of SOX9 have been reported.

If a parent has gonadal mosaicism for a mutation, the recurrence risk is increased and is higher if the parent has somatic mosaicism. There is evidence that mildly affected individuals can have children with classic features of campomelic dysplasia. Unbalanced chromosomal rearrangements within the chromosomal region encoding SOX9 inherited from a parent can also confer an increased recurrence risk.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here